These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 5001933

  • 1. Immunoassay for human calcitonin. II. Clinical studies.
    Deftos LJ, Bury AE, Habener JF, Singer FR, Potts JT.
    Metabolism; 1971 Dec; 20(12):1129-37. PubMed ID: 5001933
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Suppression and stimulation of calcitonin secretion in medullary thyroid carcinoma.
    Deftos LJ, Goodman AD, Engelman K, Potts JT.
    Metabolism; 1971 Apr; 20(4):428-31. PubMed ID: 4994451
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Limited calcitonin reserve in hyperparathyroidism.
    Becker KL, Silva OL, Wisneski LA, Cyrus J, Snider RH, Moore CF, Higgins GA.
    Am J Med Sci; 1980 Apr; 280(1):11-5. PubMed ID: 7424966
    [Abstract] [Full Text] [Related]

  • 8. [Immunoassay of calcitonin].
    Orimo H.
    Saishin Igaku; 1971 Jun; 26(6):1116-23. PubMed ID: 4938474
    [No Abstract] [Full Text] [Related]

  • 9. Radioimmunoassay for calcitonin in medullary thyroid carcinoma.
    Deftos LJ.
    JAMA; 1974 Jan 28; 227(4):403-6. PubMed ID: 4859674
    [No Abstract] [Full Text] [Related]

  • 10. The syndrome of excessive thyrocalcitonin produced by medullary carcinoma of the thyroid.
    Melvin KE, Tashjian AH.
    Proc Natl Acad Sci U S A; 1968 Apr 28; 59(4):1216-22. PubMed ID: 5240025
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Human calcitonin radioimmunoassay: characterization and application.
    Rojanasathit S, Haddad JG.
    Clin Chim Acta; 1977 Aug 01; 78(3):425-37. PubMed ID: 884868
    [Abstract] [Full Text] [Related]

  • 13. Immunoreactive calcitonin in medullary carcinoma of the thyroid and in maternal and cord serum.
    Samaan NA, Hill CS, Beceiro JR, Schultz PN.
    J Lab Clin Med; 1973 May 01; 81(5):671-81. PubMed ID: 4735426
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Calcitonin and its significance for the diagnosis of medullary carcinoma of the thyroid].
    Gautvik KM.
    Tidsskr Nor Laegeforen; 1973 May 30; 93(15):1143-8. PubMed ID: 4584540
    [No Abstract] [Full Text] [Related]

  • 16. The effect of hypocalcaemia on the secretion of calcitonin.
    West TE, O'Riordan JL, Copp DH, Bates RF, Care AD.
    J Endocrinol; 1973 Mar 30; 56(3):463-70. PubMed ID: 4633293
    [No Abstract] [Full Text] [Related]

  • 17. Hypocalcemic activity of serum in patients with medullary carcinoma of the thyroid.
    Stephens CL, Braunstein H.
    Am J Clin Pathol; 1969 Aug 30; 52(2):170-2. PubMed ID: 5798365
    [No Abstract] [Full Text] [Related]

  • 18. Radioimmunoassay of calcitonin in plasma, normal thyroid, and medullary thyroid carcinoma of the rat.
    Roos BA, Deftos LJ, Roberts G, Wilson P, Bundy L.
    J Lab Clin Med; 1976 Aug 30; 88(2):173-82. PubMed ID: 822106
    [Abstract] [Full Text] [Related]

  • 19. Basal and pentagastrin-stimulated levels of calcitonin in thyroid and peripheral veins during normocalcemia and chronic hypercalcemia in humans.
    Ericsson M, Berg M, Ingemansson S, Jernby B, Järhult J.
    Ann Surg; 1981 Aug 30; 194(2):129-33. PubMed ID: 7259337
    [Abstract] [Full Text] [Related]

  • 20. A radioimmunoassay for thyrocalcitonin.
    Deftos LJ, Lee MR, Potts JT.
    Proc Natl Acad Sci U S A; 1968 May 30; 60(1):293-9. PubMed ID: 4173038
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.